Sleep Aids (Pharmacies) - Georgia

  • Georgia
  • Revenue in the Sleep Aids market is projected to reach US$237.00k in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.20%, resulting in a market volume of US$277.40k by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.06 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in Georgia has been experiencing steady growth in recent years. Customer preferences for sleep aids have evolved, leading to changes in the market. Additionally, local special circumstances and underlying macroeconomic factors have contributed to the development of the market.

Customer preferences:
In Georgia, customers have shown an increased interest in sleep aids as they become more aware of the importance of quality sleep for overall health and well-being. Many people are experiencing high levels of stress and anxiety due to the demands of modern life, which can negatively impact sleep. As a result, there is a growing demand for sleep aids that can help individuals achieve a restful night's sleep.

Trends in the market:
One of the key trends in the Sleep Aids (Pharmacies) market in Georgia is the shift towards natural and herbal sleep aids. Customers are becoming more conscious of the potential side effects associated with traditional sleep aids and are seeking out alternative options. Natural sleep aids, such as herbal supplements and essential oils, are gaining popularity as they are perceived as safer and more gentle on the body. Another trend in the market is the increasing availability of sleep aids in pharmacies. Pharmacies are expanding their product offerings to cater to the growing demand for sleep aids. This allows customers to conveniently access a wide range of sleep aids, including prescription medications and over-the-counter remedies, in one location.

Local special circumstances:
One of the local special circumstances in Georgia that has contributed to the development of the Sleep Aids (Pharmacies) market is the high prevalence of sleep disorders. According to recent studies, a significant portion of the population in Georgia suffers from various sleep disorders, such as insomnia and sleep apnea. This has created a need for effective sleep aids that can help individuals manage their sleep disorders and improve their sleep quality. Furthermore, the increasing aging population in Georgia has also influenced the market. Older adults are more likely to experience sleep disturbances and are therefore more likely to seek out sleep aids. Pharmacies have recognized this demographic shift and have tailored their product offerings to meet the specific needs of older adults.

Underlying macroeconomic factors:
The development of the Sleep Aids (Pharmacies) market in Georgia is also influenced by underlying macroeconomic factors. The country's growing economy has resulted in an increase in disposable income, allowing individuals to spend more on healthcare products, including sleep aids. Additionally, the expanding middle class in Georgia has led to a greater awareness of health and wellness, driving the demand for sleep aids. In conclusion, the Sleep Aids (Pharmacies) market in Georgia is developing due to changing customer preferences, such as a preference for natural sleep aids, and the increasing availability of sleep aids in pharmacies. Local special circumstances, such as the high prevalence of sleep disorders and the aging population, have also contributed to the growth of the market. Furthermore, underlying macroeconomic factors, including the country's growing economy and expanding middle class, have created a favorable environment for the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)